申请人:ABBOTT LABORATORIES
公开号:EP0436199A1
公开(公告)日:1991-07-10
Certain carbocyclic aryl- and heterocyclic aryl- substituted cyclopropyl N-hydroxyureas, N-hydroxy-carboxamides, and N-acyl-N-hydroxyamines inhibit 5- and/or 12-lipoxygenase and are useful in the treatment of inflammatory disease states.
某些碳环芳基和杂环芳基取代的环丙基 N-羟基脲、N-羟基羧酰胺和 N-酰基-N-羟基胺可抑制 5-和/或 12-脂氧合酶,可用于治疗炎症性疾病。